The Big Debate

The Big Debate

<p>Join the debate today - we'd love to know your thoughts.</p>
Mar 21, 2024

The Big Debate #14: Is community pharmacy a good career choice for women?

This afternoon’s discussion will focus on the question: Is community pharmacy a good career choice for women? It’s widely discussed that a career in community pharmacy offers some flexibility which makes it more suitable for some women. Reports also show that there are more women than men in community pharmacy but less women in leadership roles. Our recent C+D Salary Survey on the gender pay gap revealed that men received on average £4k more than women in 2023. So, what are your views on this and how can we bring about change? Join the Big Debate to tell us what you think. We’re expecting lots of you will want to share your views on this important topic. Simply type your comment or question into the ‘leave a reply’ box below and let us know what you think. C+D has introduced a streamlined functionality that allows users to mention each other in a comment. Simply use ‘@’ and type in the person’s name. Join your pharmacy peers this afternoon to discuss: What are the positive and negative aspects of being a pharmacy professional for women? How can we make the sector a better environment for women leaders? Who are your female pharmacy role models and how are you inspiring the next generation of women in pharmacy? This debate will start at 1pm. The “live” part of the debate will close at 2pm, but feel free to continue to exchange views for as long as you like.
Feb 01, 2024

The Big Debate #13: Does independent prescribing move pharmacy away from its core role?

This afternoon’s discussion will focus on the question: does independent prescribing move pharmacy away from its core role? We’ve seen lots of changes in recent years as the sector makes the shift in pharmacy practice away from dispensing and towards clinical services. But is the core role of community pharmacy really changing? And are the changes brought about by independent prescribing positive or negative?  So, where along the spectrum do your own views lie? Join the Big Debate to tell us what you think. We’re expecting lots of you will want to share your views on this important topic. Simply type your comment or question into the ‘leave a reply’ box below and let us know what you think. The “live” part of the debate will close at 2pm, but feel free to continue to exchange views for as long as you like. Join your pharmacy peers this afternoon to discuss: What the core role of community pharmacy is and whether this is changing Whether changes to the shape of the job brought about by independent prescribing are positive or negative Should all pharmacists be IPs? C+D has introduced a streamlined functionality that allows users to mention each other in a comment. Simply use ‘@’ and type in the person’s name. This debate will start at 1pm.
Nov 23, 2023

The Big Debate #12: Is the MPharm still fit for purpose?

This afternoon’s discussion will focus on the question: is the MPharm still fit for purpose? We’ve seen lots of changes to the MPharm in recent years to stay in line with the shift in pharmacy practice away from dispensing and towards clinical services. But is the MPharm keeping pace with changes to everyday pharmacy practice? And is the shift towards independent prescribing in undergraduate degrees the right move? So, where along the spectrum do your own views lie? Join the Big Debate to tell us what you think. We’re expecting lots of your will want to share your views on this important topic. Simply type your comment or question into the ‘leave a reply’ box below and let us know what you think. The “live” part of the debate will close at 2pm, but feel free to continue to exchange views for as long as you like. Join your pharmacy peers this afternoon to discuss: Whether the content of the MPharm is keeping up with the realities of modern pharmacy practice What fluctuating registration exam pass rates do and don't tell us about the quality of pharmacy education The pros and cons of baking independent prescribing training into the MPharm C+D has introduced a streamlined functionality that allows users to mention each other in a comment. Simply use ‘@’ and type in the person’s name. This debate will start at 1pm.
Sep 21, 2023

The Big Debate #11: Should pharmacist recruitment into the ARRS be halted?

Tonight’s discussion will focus on the question: should pharmacist recruitment into the additional roles reimbursement system (ARRS) be halted? The ARRS, introduced in England in 2019, reimburses primary care networks (PCNs) for the salaries of several healthcare professionals – including pharmacists – as a way to help build multidisciplinary teams. The scheme has proven controversial over the past year or so. While ARRS advocates have defended it as a means by which pharmacists can gain experience working in a multidisciplinary setting, its detractors have warned of an exodus of community pharmacists as many flock to work in primary care. Some representative groups have even called for an end to the ARRS in light of “urgent…workforce issues” in community pharmacy, while others have suggested the need for pharmacy to have its own equivalent of the ARRS. But with community pharmacy’s future seemingly defined by the introduction of more clinical services, it seems clear that pharmacists’ role as the experts in medicine will become more important than ever - with PCNs eager to harness these skills. So, where along the spectrum do your own views lie? Join the Big Debate to tell us what you think. We’ve got two speakers lined up to share their views tonight, but you can also let us know your thoughts by commenting and asking questions. The “live” part of the debate will close at 8pm, but feel free to continue to exchange views for as long as you like. Join your pharmacy peers tonight to discuss: - The impact ARRS recruitment has had on community pharmacy - How it is affecting primary care - The benefits of working in general practice pharmacy - What can be done to make jobs in community pharmacy more attractive C+D has introduced a streamlined functionality that allows users to mention each other in a comment. Simply use ‘@’ and type in the person’s name. This debate will start at 7pm.
Nov 15, 2022

The Big Debate #10: What needs to be done to make community pharmacy a more attractive career prospect?

Welcome to C+D’s tenth Big Debate. Tonight’s discussion will focus on the question: What needs to be done to make community pharmacy a more attractive career prospect? Impassioned discussions within the sector over whether there is a shortage of pharmacists have intensified in recent months. While pharmacists were added to the government’s shortage occupation list in March last year, both the Home Office and the Department of Health and Social Care have since told C+D that they believe community pharmacy employers are ultimately responsible for attracting and retaining their staff. Some maintain that there is a lack of pharmacists willing to work in the sector in its current state. But some employers have argued that they struggle to retain their pharmacists due to the more attractive career prospects and higher salaries offered by primary care networks and hospitals. So, what can community pharmacy employers do to make careers in pharmacy more attractive? We’ve got three speakers lined up to share their views tonight, but you can also let us know your thoughts by commenting and asking questions. The “live” part of the debate will close at 8pm, but feel free to continue to exchange views for as long as you like. C+D has introduced a streamlined functionality that allows users to mention each other in a comment. Simply use ‘@’ and type in the person’s name. This debate will start at 7pm.
Jun 14, 2022

The Big Debate #9: Do online outlets pose a threat to community pharmacy’s reputation?

Welcome to C+D's ninth Big Debate.  Tonight’s discussion will focus on the question: “Do online outlets pose a threat to community pharmacy’s reputation?” Some online pharmacy businesses are flourishing, with the pandemic further priming the field for distance-selling outlets. However, the General Pharmaceutical Council last month revealed it had  187 open fitness-to-practise cases linked to 83 online pharmacies and, last year, it said it was considering “differentiated fees options to cover the increased regulation needed for online pharmacies”. So, should community pharmacies embrace the digital model and can these different models coexist? What safety improvements should online pharmacies implement?  Could community pharmacies learn something from online outlets? We’ve got three speakers lined up to share their views tonight, but you can also let us know your thoughts by commenting and asking questions. The “live” part of the debate will close at 8pm, but feel free to continue to exchange views for as long as you like. C+D has introduced a streamlined functionality that allows users to mention each other in a comment. Simply use ‘@’ and type in the person’s name. This debate will start at 7pm.
Feb 16, 2022

The Big Debate #7: Is getting an independent prescribing qualification worth it?

Welcome to C+D’s seventh Big Debate. Tonight’s discussion will focus on this question: “Is getting an independent prescribing qualification worth it?” Changes to the initial education and training standards for pharmacists are making prescribing a fundamental part of pharmacists’ training. But government and pharmacy bodies across Great Britain have also expressed a clear intention to upskill the existing pharmacist fleet with prescribing competencies. So, is it worth completing an IP course and getting the qualification? Are there enough chances for community pharmacists to use these skills in their daily practice? We’ve lined up five speakers who are going to share their views tonight, but you can also let us know your thoughts by commenting and asking questions. The “live” part of the debate will close at 8pm, but feel free to continue to exchange views for as long as you like. C+D has introduced a streamlined functionality that allows users to mention each other in a comment. Simply use ‘@’ and type in the person’s name. This debate will start at 7pm.
Feb 02, 2022

Future pharmacists

I’m applying for pharmacy, but as mentioned in other posts the rates have decreased drastically and some say that pharmacy is not a viable career anymore, especially with the introduction of Amazon pharmacy soon to come. What are your thoughts on this? Is pharmacy still as good a career choice as it was 20 years ago? And Is community pharmacy?
Dec 15, 2021

The Big Debate #6: Is there a shortage of community pharmacists?

The live element of this debate – which asks: is there a shortage of community pharmacists? – will start at 7pm and last until 8pm, but two of the panellists who are unable to join the live element have preprepared statements. Please find them posted below to read before the live discussion. For planned topics of conversation in this debate, see here. See you online from 7pm. Ps. C+D has introduced a streamlined functionality that allows users to mention each other in a comment. Simply use ‘@’ and type in the person’s name.
Nov 16, 2021

The Big Debate #5: How can pharmacy supervision be modernised without compromising patient safety?

Good evening everyone, welcome to our fifth Big Debate. Pharmacy supervision has been at times defined as an emotive topic, and for good reasons. But no matter on which side of the argument pharmacy professionals stand it is agreed by all that patient safety should not be compromised. A formal Community Pharmacy Supervision Practice Group – which includes members from the Association of Independent Multiple pharmacies (AIMp), the Company Chemists’ Association (CCA), the National Pharmacy Association (NPA), and the Pharmacists’ Defence Union (PDA) – first met on September 28 after sector bodies announced earlier this year that talks on pharmacy supervision had resumed. Tonight, we’ll be holding a less formal debate – although please note that we expect our participants to abide by the C+D community principles – on the following question: how can pharmacy supervision be modernised without compromising patient safety? Let us know your thoughts by commenting below. The “live” part of the debate will close at 8pm, but feel free to continue to exchange views for as long as you like. C+D has introduced a streamlined functionality that allows users to mention each other in a comment. Simply use ‘@’ and type in the person’s name.This debate will start at 7pm.

About this room

Join the Big Debate! Throughout the year, the C+D Community will open up a discussion on some of the biggest and most controversial subjects in pharmacy - whether that’s the products you stock in your pharmacy, the future of services or hot topics like remote supervision and hub-and-spoke dispensing, we'd love to hear what you think. 

Join us as we hear opposing opinions from experts and open up the floor to questions from our community members and the chance to debate some of the biggest issues in UK pharmacy today.